News & Trends - MedTech & Diagnostics
Grattan report ‘pea and thimble’ trick for private health insurance
The latest proposals from the Grattan Institute suggesting changes to community rating for private health insurance amount to no more than a complex “pea and thimble” trick that on the authors own admission, will result in older Australian’s paying more for their health insurance.
The newly released: ‘Saving private health 2: Making private health insurance viable’ claims to offer solutions to save private health insurance, but would actually do damage, says Australian Private Hospitals Association (APHA) CEO Michael Roff.
“By allowing health insurers to risk rate insurance for those under 55, anyone in this age group who has a chronic health condition, has previously had surgery or who has a history of mental health issues would effectively be priced out of the private insurance market, throwing even more demand on the overburdened public hospital system.
“The proposals rely on illusory savings from the report released last week, when the report authors calculated billions of dollars of savings based on reducing bed days for private patients – ignoring the fact the overwhelmingly private hospitals are paid per episode, not per day.
You may also like Novel Australian labs to revolutionise STEMM innovation.
“This report merely compounds the errors and misunderstandings of the private health sector the authors were so keen to talk about last week.
Mr Roff said there is, however, room for improvement in the current system.
“We have a set of policy measures for private health insurance (the private health insurance rebate, lifetime health cover and the medicare levy surcharge) that have been effective over time, but are now 20 years old. The Australian health system as a whole would benefit from some sensible adjustments to these policies to ensure they are relevant in today’s environment.
“The Grattan Institute’s complex and convoluted proposals would damage both the public and private health systems,” he said.
Register FREE to receive the latest news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.
News & Trends - MedTech & Diagnostics
AI-assisted colonoscopy boosts polyp and adenoma detection
MedTech & Diagnostics News: In a standard colonoscopy, as many as one-third of colorectal polyps and adenomas can go by […]
MoreNews & Trends - Pharmaceuticals
‘Every day of delay is costing Australian lives’, says Rare Cancers Australia CEO
Pharma News: Rare Cancers Australia (RCA) has voiced its disappointment alongside the pharmaceutical industry following the Pharmaceutical Benefits Advisory Committee’s […]
MoreNews & Trends - Pharmaceuticals
Government’s silence on Senate report leaves cancer patients in limbo
Pharma News: NeuroEndocrine Cancer Australia has urged the government to respond to the Senate report on equitable access to diagnosis […]
More